Cannabis Use Linked to Psychosis in Some Young Adults

Naturopathic News

Proponents of cannabis say that there is no harm in smoking a joint, but a new study by McGill University finds otherwise. The research indicates young adults at high risk for psychosis can aggravate their symptoms by using cannabis.

While it has been known in the scientific community that cannabis can cause psychotic episodes, including schizophrenia, the newest research backs up these claims. The study indicates a reduction in the brain’s synaptic density after cannabis consumption for those with a propensity toward psychosis. Symptoms like lack of motivation and social withdrawal are tied to decreased synaptic density.

“Not every cannabis user will develop psychosis, but for some, the risks are high. Our research helps clarify why,” said Dr. Romina Mizrahi, professor at McGill’s Department of Psychiatry and one of the study authors.

The study aims to help researchers find treatment for those at risk. Current medications do not provide relief for social withdrawal-type symptoms.

“By focusing on synaptic density, we may eventually develop therapies that enhance social function and quality of life for those affected,” said study author Belen Blasco, a PhD student at McGill’s Integrated Program in Neuroscience.

The study researched at the Douglas Mental Health University Institute and McGill University’s Montreal Neurological Institute-Hospital, was backed by the Canadian Institute of Health Research.

Researchers used state-of-the-art brain scanning techniques to study participants, aged 16 to 30. The group included young adults with existing symptoms, those considered at high risk, and control group participants without symptoms.

Source: McGill University Study https://www.mcgill.ca/newsroom/channels/news/cannabis-disrupts-brain-activity-young-adults-prone-psychosis-study-361318

Razi Ann Berry
Author: Razi Ann Berry

Current Issue

NDNR Spring 2026 of July issue

Table of Contents

The 2026 AzureWellness Summit

The 2026 AzureWellness Summit

Building a Community of Practitioners to Inspire Healthier Families  June 22–26 Five Day Virtual Event of Education, Insight, and Whole-Person Wellness AzureWell is pleased to announce the Azure Wellness Summit, a free five-day virtual event taking place June 22–26,...

Trending Articles

Restorative Formulations Launches the NeuroSynergy Clinical Series

Restorative Formulations Launches the NeuroSynergy Clinical Series

Four professional-grade formulas targeting distinct neurochemical pathways to support  mood, stress resilience, and cognitive function are now available exclusively to licensed  practitioners.  Montpelier, VT, March 27, 2026 — Restorative Formulations has released the...

Allergy Research News Release

Allergy Research News Release

RAZI BERRY Allergy Research Group Announces Peer-Reviewed Publication Advancing Thyroid and Endocrine Integration Science Collaborative research led by ARG’s Medical Affairs and Scientific Advisory Board reinforces the company’s commitment to thyroid category...

Custom Publishing

Quantum Energy Effects on Cell Recovery Rates

Quantum Energy Effects on Cell Recovery Rates

Author: Robert Sheaff, PhD, and Ian Mitchell Abstract This study investigated whether quantum field exposure generated by Leela Quantum Bloc Technology influences cell recovery rates in human cell lines. A series of double-blind experiments were conducted using Human...

Featured News

The 2026 AzureWellness Summit

The 2026 AzureWellness Summit

Building a Community of Practitioners to Inspire Healthier Families  June 22–26 Five Day Virtual Event of Education, Insight, and Whole-Person Wellness AzureWell is pleased to announce the Azure Wellness Summit, a free five-day virtual event taking place June 22–26,...